December 15, 2014

Cardinal Health has introduced a new tool that gives pharmacists the ability to rapidly analyze antibiotic use trends.

December 12, 2014

DSN examines chain pharmacy, including in-depth coverage of pharmacy technology, biosimilars and generics, as well as a look at FDA reform and its potential impact on healthcare costs, in this multi-page report.

December 12, 2014

Sanofi Pasteur announced that the FDA approved the supplemental biologics license application for Fluzone Intradermal Quadrivalent vaccine.

December 11, 2014

Mscripts has built a comprehensive digital pharmacy platform designed to improve adherence and compliance among patients. “Traditionally, we’ve focused on two-way text messaging and mobile applications,” Mark Cullen, Mscripts CEO, told Drug Store News

December 11, 2014

After a recent spike in the prices charged for some generic drugs led to outcries from pharmacists, patient advocates and federal lawmakers, a report issued last month suggests that drug costs can be controlled if the Food and Drug Administration changes the way it handles reviews and approvals.

 
December 11, 2014

Mylan on Thursday announced the launch of prednisolone sodium phosphate orally disintegrating tablets in 10-mg, 15-mg and 30-mg dosage strengths. 

 

December 11, 2014

Pharmacists, patients and payers must work together to take advantage of med sync tools and help alleviate the issue of medication nonadherence, stated B. Douglas Hoey, CEO of the National Community Pharmacists Association, in a statement issued on Thursday.

December 11, 2014

Teva Pharmaceuticals on Thursday announced the availability of levalbuterol inhalation solution, USP (concentrate), a generic equivalent to Xopenex inhalation solution concentrate. 

December 11, 2014

The Kermit Crawford era at Walgreens is drawing to a close. As of Dec. 31, Crawford, one of the industry’s best known and most respected pharmacy executives, will retire as president of pharmacy, health and wellness at the nation’s top drug store chain. 

December 11, 2014

Designed to improve patient access to pharmacists and showcase the chain’s health, wellness and daily living offerings more effectively, Walgreens’ Well Experience store format embodies the vision for a more engaged and more comprehensive model of pharmacy practice championed over the past decade by Kermit Crawford, outgoing president of pharmacy, health and wellness.

 
December 10, 2014

Teva Pharmaceutical Industries on Wednesday announced the launch of generic Celebrex (celecoxib) capsules in the United States. The company is offering the capsules in 50-,100-, 200- and 400-mg dosage strengths. 

 

December 9, 2014

The Generic Pharmaceutical Association agreed to support compromise automatic substitution legislation.

December 9, 2014

Mirixa Corp. announced a partnership with pharmacy system PioneerRx on a patient adherence solution.

December 9, 2014

Reps. Doug Collins, R-Ga., and Dave Loebsack, D-Iowa, introduced on Tuesday H.R. 5815 — the Generic Drug Pricing Fairness Act — which creates greater transparency in how PBMs reimburse pharmacies for generic prescription drugs under Medicare Part D, the military’s TRICARE program, and the Federal Employees Health Benefits Program.

December 9, 2014

From 2009 to 2013, the number of Americans using prescription opiates declined 9.2%, yet both the number of opioid prescriptions filled and the number of days of medication per prescription rose more than 8% in that time period. 

December 9, 2014

Teva Canada, a subsidiary of Teva Pharmaceutical Industries, announced Tuesday that Health Canada has approved its application for the generic version of PrTarceva. 

December 8, 2014

Acura Pharmaceuticals on Monday announced that the company has been issued its first U.S. patent directed at the company's Impede technology and products utilizing that technology. 

December 8, 2014

Fruth Pharmacy, which operates 27 stores in Ohio and West Virginia, has introduced a new program called “Gopher” to the community.

December 8, 2014
Kroger and Medicine Shoppe are participating in MediMergent's pilot study of the National Medication Safety, Outcomes and Adherence Program.
December 8, 2014

The pros of giving healthy women regular low dose aspirin to stave off such serious illness as cancer and heart disease are outweighed by the cons, suggests a large study published online last week in the journal Heart.

December 8, 2014

As Congress continues consideration of the bipartisan conference agreement to the FY 2015 National Defense Authorization Act, National Association of Chain Drug Stores president and CEO Steve Anderson issued a statement.

December 5, 2014

The FDA issued a draft guidance that would provide generic companies a pathway to obtain samples of medicines requiring a Risk Evaluation and Mitigation Strategy (REMS) protocol for product testing.

December 4, 2014

Mylan on Thursday announced that its subsidiary, Mylan Labs, was granted tentative approval from the Food and Drug Administration for two dosages of abacavir/lamivudine tablets for oral suspension. 

December 3, 2014

The Food and Drug Administration published a final rule that sets standards for how information about using medicines during pregnancy and breastfeeding is presented in the labeling of prescription drugs and biological products.